The COVID-19 Vaccine and Current Debate onVaccination Policies

Abstract

We read with interest the Letter to the Editor entitled “COVID-19 vaccine prioritization must be driven by science”by Yale et al., published recently in the Erciyes Medical Journal (1). It is well known that the new human viralpathogen, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is the etiologic agent of coronavirusdisease 2019 (COVID-19). After the emergence of COVID-19 in December 2019 in Wuhan, China and its sub sequent rapid spread around the world, vaccine development studies were initiated in many countries (2). In lessthan a year, intense scientific work has resulted in the development of numerous vaccines with different mecha nisms of action. However, the speed and process of vaccine development and administration have raised concernsregarding their efficacy and safety.